Review



flu influenza peptides  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Miltenyi Biotec flu influenza peptides
    Flu Influenza Peptides, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/PepTivator+CEF+MHC+Class+I+Plus%2C+premium+grade/bio_rxiv__64898__2026__06__04__730166-48-57-60
    Average 94 stars, based on 16 article reviews
    flu influenza peptides - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Staining:

    Article Title: Blimp-1 integrates alarmin signals in ILC2s and drives proinflammatory functions required for type 2 immunity
    Article Snippet: .. For surface staining, the following antibodies were used: CD101 (REA301, Miltenyi), c-Kit (2B8), CD11b (M1/70), CD11c (N418), IL-25R (Munc33), CD127 (A7R34), CD19 (1D3), CD4 (GK1.5 and RM4-5), CD45 (30-F11) or CD45.2 (104), CD90 (30H12), F4/80 (BM8), KLRG1 (2F1 or MAFA), NK1.1 (PK136), PD-1 (29F.1A12), Sca-1 (D7), Siglec F (E50-2440), ST2 (RMST2-33), and TSLPR (22H9). ..

    Article Title: GABA agonists and antagonists affect differentiation of hematopoietic stem cells and megakaryocyte progenitors
    Article Snippet: .. Then, to enrich HSCs and progenitor populations, cells were stained with APC-conjugated anti-c-Kit (2B8) and then with anti-APC magnetic beads (Miltenyi Biotec) after washing. .. The c-Kit+cells were eluted from LS columns (Miltenyi Biotec).

    Virus:

    Article Title: Preserved CD4 + T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapy
    Article Snippet: .. Cells were then stimulated overnight with 3 μg/ml of HBV capsid/core peptides (JPT Peptide Technologies, Catalogue# PM-HBV-CP; 44 peptides, 15-mers overlapping by 11 amino acids), HBV envelope peptides (JPT Peptide Technologies, Catalogue# PM-HBV-LEPULTRA; 121 peptides, 15-mer peptides), HIV-1 Gag peptides (JPT Peptide Technologies, Catalogue# PM-HIV-GAG; 150 peptides, 15-mer peptides), and CEF (Cytomegalovirus (CMV), Epstein-Barr virus (EBV), and Flu (Influenza)) peptides (Miltenyi Biotec, Catalogue# 130-098-426; 32 peptides), or with 0.005% DMSO as a negative control in the presence of αCD28/αCD49d (1 μg/ml) GolgiStop (containing Monensin, 2 μmol/l), GolgiPlug (containing brefeldin A, 10 μg/ml) (BD Biosciences) and anti-CD107α APC/Cy7 antibody (BD Biosciences, Catalogue# 561343, dilution 1 in 50). .. After stimulation, cells were washed and stained with anti-CCR7 for 30 min at 37 °C and then surface-stained at 4 °C for 20 min with different combinations of surface antibodies in the presence of fixable live/dead stain (Invitrogen Catalogue # L34957, dilution 1 in 300).

    Negative Control:

    Article Title: Preserved CD4 + T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapy
    Article Snippet: .. Cells were then stimulated overnight with 3 μg/ml of HBV capsid/core peptides (JPT Peptide Technologies, Catalogue# PM-HBV-CP; 44 peptides, 15-mers overlapping by 11 amino acids), HBV envelope peptides (JPT Peptide Technologies, Catalogue# PM-HBV-LEPULTRA; 121 peptides, 15-mer peptides), HIV-1 Gag peptides (JPT Peptide Technologies, Catalogue# PM-HIV-GAG; 150 peptides, 15-mer peptides), and CEF (Cytomegalovirus (CMV), Epstein-Barr virus (EBV), and Flu (Influenza)) peptides (Miltenyi Biotec, Catalogue# 130-098-426; 32 peptides), or with 0.005% DMSO as a negative control in the presence of αCD28/αCD49d (1 μg/ml) GolgiStop (containing Monensin, 2 μmol/l), GolgiPlug (containing brefeldin A, 10 μg/ml) (BD Biosciences) and anti-CD107α APC/Cy7 antibody (BD Biosciences, Catalogue# 561343, dilution 1 in 50). .. After stimulation, cells were washed and stained with anti-CCR7 for 30 min at 37 °C and then surface-stained at 4 °C for 20 min with different combinations of surface antibodies in the presence of fixable live/dead stain (Invitrogen Catalogue # L34957, dilution 1 in 300).

    Immunopeptidomics:

    Article Title: Inhibitors of MHC-I Nef downmodulation for treating HIV
    Article Snippet: Flow Cytometry Surface Staining All flow cytometry stains were performed on ice in FACS buffer (2% fetal bovine serum, 1% human serum (Fisher, BP2525), 2 mM HEPES, 0.025% sodium azide (Sigma) in PBS). .. Primary antibodies against the following proteins were used: HLA-A2 (BB7.2 from HB-82 hybridoma as previously described, 0.5 μg/mL), Bw4 (Bw4-APC (Miltenyi, 130-103-848, 1:50), Bw6 (Bw6-APC (Miltenyi, 130-099-845, 1:50)), pan MHC (w6/32 (Fisher, MA1-70111, 1:1000), PLAP (PLAP-647 (Santa Cruz Biotechnology, clone 8B6, 1:1000), CD4 (Fisher, 555344, 1:1000), and HA (HA.11, Covance, 1:100). .. Primary antibodies against the following proteins were used: HLA-A2 (BB7.2 from HB-82 hybridoma as previously described, 0.5 μg/mL), Bw4 (Bw4-APC (Miltenyi, 130-103-848, 1:50), Bw6 (Bw6-APC (Miltenyi, 130-099-845, 1:50)), pan MHC (w6/32 (Fisher, MA1-70111, 1:1000), PLAP (PLAP-647 (Santa Cruz Biotechnology, clone 8B6, 1:1000), CD4 (Fisher, 555344, 1:1000), and HA (HA.11, Covance, 1:100).

    Article Title: Cytokine-bearing Bacterial Outer Membrane Vesicles with Empowered Efficacy in Intratumoral Immunotherapy
    Article Snippet: A) 25 μL of the following mixture of fluorescent-labeled antibodies were added to the samples: CD3-APC (BioLegend, San Diego, CA, USA), CD4-BV510 (BioLegend, San Diego, CA, USA), CD8a-PECF594 (BD Bioscience, San Jose, CA, USA), CD25-PE-Vio770 (Miltenyi Biotech, Bergisch Gladbach, Germany), MHC II (I-Ek)-VioBright (Miltenyi Biotech, Bergisch Gladbach, Germany), CD11b-BV785 (BD Bioscience, San Jose, CA, USA) and Ly6C/Ly6G-BV421 (BD Bioscience, San Jose, CA, USA). .. B) 25 μL of the following mixture of fluorescent-labeled antibodies were added to the samples: CD3-APC (BioLegend, San Diego, CA, USA), CD4-BV510 (BioLegend, San Diego, CA, USA), CD8a-PECF594 (BD Bioscience, San Jose, CA, USA), TCRγδ-PE (Miltenyi Biotech, Bergisch Gladbach, Germany), TCRαβ-PEVio770 (Miltenyi Biotech, Bergisch Gladbach, Germany) and MHC II (I-Ek)-VioBright (Miltenyi Biotech, Bergisch Gladbach, Germany). ..

    Article Title: Cytokine-bearing Bacterial Outer Membrane Vesicles with Empowered Efficacy in Intratumoral Immunotherapy
    Article Snippet: .. A) 25 μL of the following mixture of fluorescent-labeled antibodies were added to the samples: CD3-APC (BioLegend, San Diego, CA, USA), CD4-BV510 (BioLegend, San Diego, CA, USA), CD8a-PECF594 (BD Bioscience, San Jose, CA, USA), CD25-PE-Vio770 (Miltenyi Biotech, Bergisch Gladbach, Germany), MHC II (I-Ek)-VioBright (Miltenyi Biotech, Bergisch Gladbach, Germany), CD11b-BV785 (BD Bioscience, San Jose, CA, USA) and Ly6C/Ly6G-BV421 (BD Bioscience, San Jose, CA, USA). .. B) 25 μL of the following mixture of fluorescent-labeled antibodies were added to the samples: CD3-APC (BioLegend, San Diego, CA, USA), CD4-BV510 (BioLegend, San Diego, CA, USA), CD8a-PECF594 (BD Bioscience, San Jose, CA, USA), TCRγδ-PE (Miltenyi Biotech, Bergisch Gladbach, Germany), TCRαβ-PEVio770 (Miltenyi Biotech, Bergisch Gladbach, Germany) and MHC II (I-Ek)-VioBright (Miltenyi Biotech, Bergisch Gladbach, Germany).

    Magnetic Beads:

    Article Title: GABA agonists and antagonists affect differentiation of hematopoietic stem cells and megakaryocyte progenitors
    Article Snippet: .. Then, to enrich HSCs and progenitor populations, cells were stained with APC-conjugated anti-c-Kit (2B8) and then with anti-APC magnetic beads (Miltenyi Biotec) after washing. .. The c-Kit+cells were eluted from LS columns (Miltenyi Biotec).

    other:

    Article Title: Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer
    Article Snippet: anti-human HLA-G Alexa Fluor 700 , Miltenyi , 130-129-292.



    Similar Products

    94
    Miltenyi Biotec flu influenza peptides
    Flu Influenza Peptides, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/PepTivator+CEF+MHC+Class+I+Plus%2C+premium+grade/bio_rxiv__64898__2026__06__04__730166-48-57-60
    Average 94 stars, based on 1 article reviews
    flu influenza peptides - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress anti mouse mhc class i h 2kb antibody
    Anti Mouse Mhc Class I H 2kb Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/Anti-Mouse+MHC+Class+I+(H-2Kb)+Antibody/pmc13198314-25-0-8
    Average 94 stars, based on 1 article reviews
    anti mouse mhc class i h 2kb antibody - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology h 2kb
    H 2kb, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/MHC+class+I+Antibody/pm42822278-47-18-19
    Average 95 stars, based on 1 article reviews
    h 2kb - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    97
    Elabscience Biotechnology c clone w6 32 elabscience
    C Clone W6 32 Elabscience, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/MHC+class+I+Monoclonal+Antibody/pm42804096-75-6-9
    Average 97 stars, based on 1 article reviews
    c clone w6 32 elabscience - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    93
    Proteintech hla c
    Hla C, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/HLA+class+I+(HLA-C)+Antibody/pm42532044-526-6-9
    Average 93 stars, based on 1 article reviews
    hla c - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    95
    Proteintech hla class i abc
    Hla Class I Abc, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/HLA+class+I+ABC+Antibody/pm42532044-526-10-17
    Average 95 stars, based on 1 article reviews
    hla class i abc - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology mhc i
    Mhc I, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/MHC+class+I+Rabbit+mAb/pm42458540-84-8-10
    Average 94 stars, based on 1 article reviews
    mhc i - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    86
    Leinco Technologies b7 mhc class i
    B7 Mhc Class I, supplied by Leinco Technologies, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/anti+blocking+class+ii+mhc/pmc13200046-8-3-10
    Average 86 stars, based on 1 article reviews
    b7 mhc class i - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Sanofi class i hdac inhibitor hdaci valproate
    A Glucose metabolism. Studied metabolic pathways are in bold. B Box plots of standardized expression sum (SES), by RNA-seq, of genes within metabolic pathways in CD4 + cells of RA ( n = 11), healthy controls (HC, n = 57), and of CD4 + cells split by mean expression of BIRC5 gene in high (B5 hi ) and low (B5 lo ) ( n = 24). Boxes indicate IQR and whiskers indicate the minimum and maximum values. GO-terms used for pathway annotation: Glycolysis (GO:0006096); oxidative phosphorylation (OxPhos, GO:0006119 and GO:0022900); pentose phosphate pathway (PPP, GO:0006098); tricarboxylic acid cycle (TCA, GO:0006099). P -values are calculated by Wilcoxon unpaired test. C Heatmap of Spearman’s correlation between HAT, <t>HDAC</t> and metabolic pathways as above. GO-terms used for annotation HAT (GO:0000123) and HDAC (GO:0000118). Asterisks indicate p -values. * < 0.05, ** < 0.01, *** <0.001. D Heatmap of Spearman’s correlation between HAT and HDAC and insulin signaling (IS). Asterisks indicate p -values * < 0.05, ** < 0.01, *** <0.001. E Scatter plot of Spearman’s correlation between plasma insulin levels and SES of insulin signaling. F Uniform manifold approximation and projection (UMAP) map of scaled expression intensity of BIRC5 , IFNG , and TNF in T cells of RA synovial tissue (ST), by single cell transcriptome. BIRC5 Hi CD4 + clusters are indicated. G Heatmap of scaled expression intensity of metabolic pathway (annotated as above) in peripheral blood (PB), synovial fluid (SF), and ST of RA patients, by scRNA-seq. H Violin plot of insulin signaling by SES of INSR, IRS1, IRS2 and IGF1R genes in BIRC5 Hi CD4 + clusters. P-value was calculated by chi-square test. I Violin plot of metabolic pathways SES in cells with high and low IS in BIRC5 Hi CD4 + clusters. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001 J . Box plot of BIRC5, IFNG , and TNF expression in Tph cells with high and low IS. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon unpaired test. K Heatmap of expression for IL7R-signaling targets in Tph cells high and low IS. Genes regulated by survivin-H3K27ac are in bold. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.
    Class I Hdac Inhibitor Hdaci Valproate, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/hdac+hdaci+inhibitor+valproate/pmc13201554-277-40-52
    Average 86 stars, based on 1 article reviews
    class i hdac inhibitor hdaci valproate - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Glaxo Smith topical class i corticosteroid
    A Glucose metabolism. Studied metabolic pathways are in bold. B Box plots of standardized expression sum (SES), by RNA-seq, of genes within metabolic pathways in CD4 + cells of RA ( n = 11), healthy controls (HC, n = 57), and of CD4 + cells split by mean expression of BIRC5 gene in high (B5 hi ) and low (B5 lo ) ( n = 24). Boxes indicate IQR and whiskers indicate the minimum and maximum values. GO-terms used for pathway annotation: Glycolysis (GO:0006096); oxidative phosphorylation (OxPhos, GO:0006119 and GO:0022900); pentose phosphate pathway (PPP, GO:0006098); tricarboxylic acid cycle (TCA, GO:0006099). P -values are calculated by Wilcoxon unpaired test. C Heatmap of Spearman’s correlation between HAT, <t>HDAC</t> and metabolic pathways as above. GO-terms used for annotation HAT (GO:0000123) and HDAC (GO:0000118). Asterisks indicate p -values. * < 0.05, ** < 0.01, *** <0.001. D Heatmap of Spearman’s correlation between HAT and HDAC and insulin signaling (IS). Asterisks indicate p -values * < 0.05, ** < 0.01, *** <0.001. E Scatter plot of Spearman’s correlation between plasma insulin levels and SES of insulin signaling. F Uniform manifold approximation and projection (UMAP) map of scaled expression intensity of BIRC5 , IFNG , and TNF in T cells of RA synovial tissue (ST), by single cell transcriptome. BIRC5 Hi CD4 + clusters are indicated. G Heatmap of scaled expression intensity of metabolic pathway (annotated as above) in peripheral blood (PB), synovial fluid (SF), and ST of RA patients, by scRNA-seq. H Violin plot of insulin signaling by SES of INSR, IRS1, IRS2 and IGF1R genes in BIRC5 Hi CD4 + clusters. P-value was calculated by chi-square test. I Violin plot of metabolic pathways SES in cells with high and low IS in BIRC5 Hi CD4 + clusters. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001 J . Box plot of BIRC5, IFNG , and TNF expression in Tph cells with high and low IS. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon unpaired test. K Heatmap of expression for IL7R-signaling targets in Tph cells high and low IS. Genes regulated by survivin-H3K27ac are in bold. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.
    Topical Class I Corticosteroid, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/class+i/class+corticosteroid+i+topical/pmc13282020-25-8-16
    Average 86 stars, based on 1 article reviews
    topical class i corticosteroid - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    Image Search Results


    A Glucose metabolism. Studied metabolic pathways are in bold. B Box plots of standardized expression sum (SES), by RNA-seq, of genes within metabolic pathways in CD4 + cells of RA ( n = 11), healthy controls (HC, n = 57), and of CD4 + cells split by mean expression of BIRC5 gene in high (B5 hi ) and low (B5 lo ) ( n = 24). Boxes indicate IQR and whiskers indicate the minimum and maximum values. GO-terms used for pathway annotation: Glycolysis (GO:0006096); oxidative phosphorylation (OxPhos, GO:0006119 and GO:0022900); pentose phosphate pathway (PPP, GO:0006098); tricarboxylic acid cycle (TCA, GO:0006099). P -values are calculated by Wilcoxon unpaired test. C Heatmap of Spearman’s correlation between HAT, HDAC and metabolic pathways as above. GO-terms used for annotation HAT (GO:0000123) and HDAC (GO:0000118). Asterisks indicate p -values. * < 0.05, ** < 0.01, *** <0.001. D Heatmap of Spearman’s correlation between HAT and HDAC and insulin signaling (IS). Asterisks indicate p -values * < 0.05, ** < 0.01, *** <0.001. E Scatter plot of Spearman’s correlation between plasma insulin levels and SES of insulin signaling. F Uniform manifold approximation and projection (UMAP) map of scaled expression intensity of BIRC5 , IFNG , and TNF in T cells of RA synovial tissue (ST), by single cell transcriptome. BIRC5 Hi CD4 + clusters are indicated. G Heatmap of scaled expression intensity of metabolic pathway (annotated as above) in peripheral blood (PB), synovial fluid (SF), and ST of RA patients, by scRNA-seq. H Violin plot of insulin signaling by SES of INSR, IRS1, IRS2 and IGF1R genes in BIRC5 Hi CD4 + clusters. P-value was calculated by chi-square test. I Violin plot of metabolic pathways SES in cells with high and low IS in BIRC5 Hi CD4 + clusters. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001 J . Box plot of BIRC5, IFNG , and TNF expression in Tph cells with high and low IS. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon unpaired test. K Heatmap of expression for IL7R-signaling targets in Tph cells high and low IS. Genes regulated by survivin-H3K27ac are in bold. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.

    Journal: Cell Death & Disease

    Article Title: Insulin enables acquisition of the IL7R + memory phenotype in PD1 + T cells in RA tissues

    doi: 10.1038/s41419-026-08916-6

    Figure Lengend Snippet: A Glucose metabolism. Studied metabolic pathways are in bold. B Box plots of standardized expression sum (SES), by RNA-seq, of genes within metabolic pathways in CD4 + cells of RA ( n = 11), healthy controls (HC, n = 57), and of CD4 + cells split by mean expression of BIRC5 gene in high (B5 hi ) and low (B5 lo ) ( n = 24). Boxes indicate IQR and whiskers indicate the minimum and maximum values. GO-terms used for pathway annotation: Glycolysis (GO:0006096); oxidative phosphorylation (OxPhos, GO:0006119 and GO:0022900); pentose phosphate pathway (PPP, GO:0006098); tricarboxylic acid cycle (TCA, GO:0006099). P -values are calculated by Wilcoxon unpaired test. C Heatmap of Spearman’s correlation between HAT, HDAC and metabolic pathways as above. GO-terms used for annotation HAT (GO:0000123) and HDAC (GO:0000118). Asterisks indicate p -values. * < 0.05, ** < 0.01, *** <0.001. D Heatmap of Spearman’s correlation between HAT and HDAC and insulin signaling (IS). Asterisks indicate p -values * < 0.05, ** < 0.01, *** <0.001. E Scatter plot of Spearman’s correlation between plasma insulin levels and SES of insulin signaling. F Uniform manifold approximation and projection (UMAP) map of scaled expression intensity of BIRC5 , IFNG , and TNF in T cells of RA synovial tissue (ST), by single cell transcriptome. BIRC5 Hi CD4 + clusters are indicated. G Heatmap of scaled expression intensity of metabolic pathway (annotated as above) in peripheral blood (PB), synovial fluid (SF), and ST of RA patients, by scRNA-seq. H Violin plot of insulin signaling by SES of INSR, IRS1, IRS2 and IGF1R genes in BIRC5 Hi CD4 + clusters. P-value was calculated by chi-square test. I Violin plot of metabolic pathways SES in cells with high and low IS in BIRC5 Hi CD4 + clusters. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001 J . Box plot of BIRC5, IFNG , and TNF expression in Tph cells with high and low IS. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon unpaired test. K Heatmap of expression for IL7R-signaling targets in Tph cells high and low IS. Genes regulated by survivin-H3K27ac are in bold. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.

    Article Snippet: Cells were stimulated with concanavalin A (ConA, 0.625 μg/mL, MP Biomedicals), and lipopolysaccharide (LPS, 5 μg/mL, Sigma-Aldrich) for 48 h. For immunophenotyping, the cultures were supplemented with insulin (Humalog 100 U/mL, Eli Lilly, Indianapolis, IN, USA) 25 nM and/or the class I HDAC inhibitor (HDACi) valproate, 50 μg/mL (stock 200 mg/mL, Ergenyl, Sanofi, Paris, France) after 24 h. Supernatants were collected for cytokine measures and cells were analyzed by flow cytometry.

    Techniques: Expressing, RNA Sequencing, Phospho-proteomics, Clinical Proteomics, Single Cell

    A Confocal microscopy images of THP1 cells stained with antibodies to H3K27ac (red) in nucleus (blue) after stimulation with insulin (top), and HDAC-inhibitor (bottom) for 24 h. Images are acquired with 40× magnification with additional digital magnification 1.5×. B Scatter plot of nuclear H3K27ac staining intensity after stimulation with insulin (top) and HDAC-inhibitor (bottom). P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. C Histogram of phosphorylated serine 473 (p)AKT1 mean fluorescence intensity in THP1 cells stimulated with 10 nM insulin, by flow cytometry. D Histogram of H3K27ac mean fluorescence intensity in THP1 cells stimulated with increasing concentrations of insulin for 24 h, by flow cytometry. E Histogram of pAKT1 mean fluorescence intensity in human lymphocytes stimulated with increasing concentrations of insulin for 30 min, by flow cytometry.

    Journal: Cell Death & Disease

    Article Title: Insulin enables acquisition of the IL7R + memory phenotype in PD1 + T cells in RA tissues

    doi: 10.1038/s41419-026-08916-6

    Figure Lengend Snippet: A Confocal microscopy images of THP1 cells stained with antibodies to H3K27ac (red) in nucleus (blue) after stimulation with insulin (top), and HDAC-inhibitor (bottom) for 24 h. Images are acquired with 40× magnification with additional digital magnification 1.5×. B Scatter plot of nuclear H3K27ac staining intensity after stimulation with insulin (top) and HDAC-inhibitor (bottom). P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. C Histogram of phosphorylated serine 473 (p)AKT1 mean fluorescence intensity in THP1 cells stimulated with 10 nM insulin, by flow cytometry. D Histogram of H3K27ac mean fluorescence intensity in THP1 cells stimulated with increasing concentrations of insulin for 24 h, by flow cytometry. E Histogram of pAKT1 mean fluorescence intensity in human lymphocytes stimulated with increasing concentrations of insulin for 30 min, by flow cytometry.

    Article Snippet: Cells were stimulated with concanavalin A (ConA, 0.625 μg/mL, MP Biomedicals), and lipopolysaccharide (LPS, 5 μg/mL, Sigma-Aldrich) for 48 h. For immunophenotyping, the cultures were supplemented with insulin (Humalog 100 U/mL, Eli Lilly, Indianapolis, IN, USA) 25 nM and/or the class I HDAC inhibitor (HDACi) valproate, 50 μg/mL (stock 200 mg/mL, Ergenyl, Sanofi, Paris, France) after 24 h. Supernatants were collected for cytokine measures and cells were analyzed by flow cytometry.

    Techniques: Confocal Microscopy, Staining, Fluorescence, Flow Cytometry

    A Analysis strategy of survivin and H3K27ac deposition, by ChIP-seq, in cis-regulatory elements ( cis -RE) and connected genes in human CD4 + T cells. B Venn diagram of insulin-responsive (InsResp) genes connected to cis -RE with survivin-H3K27ac co-deposition. Genes are identified by DESeq2 analysis of CD4 + cells transcriptome after a) direct insulin stimulation (InsStim) and b) in regression to corresponding plasma insulin levels, by RNA-seq. C Scatter plot of pathway enrichment of insulin-responsive genes, by GSEA GO-terms. Circle size indicates the number of genes in the pathway, and color intensity indicates p -value. D Venn diagram of insulin-responsive (InsResp) genes connected to cis -RE with H3K27ac deposition. Genes are identified by DESeq2 analysis of CD4 + cells transcriptome after a) direct insulin stimulation (InsStim) and b) HDAC inhibition. E Scatter plot of protein subunits with survivin-H3K27ac in HAT (E1) and HDAC (E3) complexes, annotated by STRING database. Circle size represents number of cis- RE with survivin-H3K27ac connected to the gene. Circle color represents beta-coefficient of expression difference by DESeq2 analysis of CD4 + cell transcriptome in regression to corresponding plasma insulin levels. (E2 and E4) Heatmap of transcription difference, by log2FoldChange (FC), in CD4 + cells in regression to plasma insulin levels (InsReg), and after HDAC inhibitor treatment in vitro. F . Bar plot of percentage of H3K27ac and survivin-H3K27ac connected genes in each metabolic pathway. GO-terms used for pathway annotation as in Fig. . G Scatter plot of expression difference of survivin-H3K27ac connected genes in transcriptome of CD4 + cells in regression to plasma insulin levels and after HDACi treatment, by RNA-seq. Expression difference is calculated by DESeq2 analysis. Colour fill corresponds to metabolic pathway annotation of the gene.

    Journal: Cell Death & Disease

    Article Title: Insulin enables acquisition of the IL7R + memory phenotype in PD1 + T cells in RA tissues

    doi: 10.1038/s41419-026-08916-6

    Figure Lengend Snippet: A Analysis strategy of survivin and H3K27ac deposition, by ChIP-seq, in cis-regulatory elements ( cis -RE) and connected genes in human CD4 + T cells. B Venn diagram of insulin-responsive (InsResp) genes connected to cis -RE with survivin-H3K27ac co-deposition. Genes are identified by DESeq2 analysis of CD4 + cells transcriptome after a) direct insulin stimulation (InsStim) and b) in regression to corresponding plasma insulin levels, by RNA-seq. C Scatter plot of pathway enrichment of insulin-responsive genes, by GSEA GO-terms. Circle size indicates the number of genes in the pathway, and color intensity indicates p -value. D Venn diagram of insulin-responsive (InsResp) genes connected to cis -RE with H3K27ac deposition. Genes are identified by DESeq2 analysis of CD4 + cells transcriptome after a) direct insulin stimulation (InsStim) and b) HDAC inhibition. E Scatter plot of protein subunits with survivin-H3K27ac in HAT (E1) and HDAC (E3) complexes, annotated by STRING database. Circle size represents number of cis- RE with survivin-H3K27ac connected to the gene. Circle color represents beta-coefficient of expression difference by DESeq2 analysis of CD4 + cell transcriptome in regression to corresponding plasma insulin levels. (E2 and E4) Heatmap of transcription difference, by log2FoldChange (FC), in CD4 + cells in regression to plasma insulin levels (InsReg), and after HDAC inhibitor treatment in vitro. F . Bar plot of percentage of H3K27ac and survivin-H3K27ac connected genes in each metabolic pathway. GO-terms used for pathway annotation as in Fig. . G Scatter plot of expression difference of survivin-H3K27ac connected genes in transcriptome of CD4 + cells in regression to plasma insulin levels and after HDACi treatment, by RNA-seq. Expression difference is calculated by DESeq2 analysis. Colour fill corresponds to metabolic pathway annotation of the gene.

    Article Snippet: Cells were stimulated with concanavalin A (ConA, 0.625 μg/mL, MP Biomedicals), and lipopolysaccharide (LPS, 5 μg/mL, Sigma-Aldrich) for 48 h. For immunophenotyping, the cultures were supplemented with insulin (Humalog 100 U/mL, Eli Lilly, Indianapolis, IN, USA) 25 nM and/or the class I HDAC inhibitor (HDACi) valproate, 50 μg/mL (stock 200 mg/mL, Ergenyl, Sanofi, Paris, France) after 24 h. Supernatants were collected for cytokine measures and cells were analyzed by flow cytometry.

    Techniques: ChIP-sequencing, Clinical Proteomics, RNA Sequencing, Inhibition, Expressing, In Vitro

    A Transition model of PD1 hi Tph cells to the IL7R + T memory cells, influenced by insulin and HDAC inhibition. B Box plot of protein cytokine levels in supernatants of CD4 + cells ( n = 12) stimulated with insulin (25 nM) and HDACi (50 µg/mL) for 24 h, by ELISA. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon Sign rank test. C Gating strategy to CD4 + T cell subset analysis by flow cytometry. D Box plot of PD1 and CD27 expression in CD4 + cells ( n = 8) stimulated by insulin and HDACi, by mean fluorescence intensity (MFI). Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon Sign rank paired test. E Heatmap of expression difference of IL7R-related signaling molecules in CD4 + cells after in vitro stimulation with insulin (25 nM), HDACi (50 µg/mL), IFNγ (50 ng/ml), and survivin inhibitor YM155 (10 μM), by RNA-seq. Genes connected to cis -RE containing survivin-H3K27ac co-deposition are indicated bold. Asterisks indicate RNA-seq p -values * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. F Heatmap showing expression difference, by log2FC, of cluster markers of Tph cluster after insulin stimulation, HDAC inhibition. In bold are the genes supervised by a cis-RE containing survivin-H3K27ac deposition. P -values are calculated by DESeq2 analysis. Asterisks indicate nominal p -values * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.

    Journal: Cell Death & Disease

    Article Title: Insulin enables acquisition of the IL7R + memory phenotype in PD1 + T cells in RA tissues

    doi: 10.1038/s41419-026-08916-6

    Figure Lengend Snippet: A Transition model of PD1 hi Tph cells to the IL7R + T memory cells, influenced by insulin and HDAC inhibition. B Box plot of protein cytokine levels in supernatants of CD4 + cells ( n = 12) stimulated with insulin (25 nM) and HDACi (50 µg/mL) for 24 h, by ELISA. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon Sign rank test. C Gating strategy to CD4 + T cell subset analysis by flow cytometry. D Box plot of PD1 and CD27 expression in CD4 + cells ( n = 8) stimulated by insulin and HDACi, by mean fluorescence intensity (MFI). Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon Sign rank paired test. E Heatmap of expression difference of IL7R-related signaling molecules in CD4 + cells after in vitro stimulation with insulin (25 nM), HDACi (50 µg/mL), IFNγ (50 ng/ml), and survivin inhibitor YM155 (10 μM), by RNA-seq. Genes connected to cis -RE containing survivin-H3K27ac co-deposition are indicated bold. Asterisks indicate RNA-seq p -values * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. F Heatmap showing expression difference, by log2FC, of cluster markers of Tph cluster after insulin stimulation, HDAC inhibition. In bold are the genes supervised by a cis-RE containing survivin-H3K27ac deposition. P -values are calculated by DESeq2 analysis. Asterisks indicate nominal p -values * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.

    Article Snippet: Cells were stimulated with concanavalin A (ConA, 0.625 μg/mL, MP Biomedicals), and lipopolysaccharide (LPS, 5 μg/mL, Sigma-Aldrich) for 48 h. For immunophenotyping, the cultures were supplemented with insulin (Humalog 100 U/mL, Eli Lilly, Indianapolis, IN, USA) 25 nM and/or the class I HDAC inhibitor (HDACi) valproate, 50 μg/mL (stock 200 mg/mL, Ergenyl, Sanofi, Paris, France) after 24 h. Supernatants were collected for cytokine measures and cells were analyzed by flow cytometry.

    Techniques: Inhibition, Enzyme-linked Immunosorbent Assay, Flow Cytometry, Expressing, Fluorescence, In Vitro, RNA Sequencing